Epigenetic analyses suggest different pathways during pregnancy for development of type 1 diabetes in children with high versus low‐neutral human leukocyte antigen‐risk
Journal of Internal Medicine · 2026-05 · 299 (5) · 570-586
DOI: 10.1111/joim.70077 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Internal Medicine, online erschienen am 25.02.2026. Verfasst von Shamila D Alipoor und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatrics, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, HLA Antigens, Epigenesis, Genetic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council of Southeast Sweden (FORSS); JDRF Wallenberg Foundation.
Themen: Diabetes mellitus, Kinderkrankenpflege
Abstract (Originalsprache)
Background and objective The development of Type 1 diabetes (T1D) is shaped by genetic predisposition and epigenetic regulation. Human leukocyte antigen (HLA) risk alleles are major genetic determinants, but the epigenetic landscape in relation to disease onset remains unclear. Early‐life epigenetic modifications may reveal how environmental and epigenetic factors interact in T1D pathogenesis.
Methods
We investigated epigenetic differences in cord blood DNA from individuals with different HLA risk alleles who later developed T1D using epigenome‐wide association studies.
Result
High‐risk HLA carriers showed differentially methylated genes (DMGs) mainly involved in immune and autoimmune processes, resembling patterns in other autoimmune diseases. In contrast, low‐to‐neutral risk carriers exhibited DMGs linked to signaling cascades, metabolic pathways, and Type 2 diabetes–related mechanisms such as beta cell function and insulin signaling.
Conclusion
These findings indicate that heterogeneity in T1D pathogenetic mechanisms based on HLA background may influence disease development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatrics, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
- Department of Biomedical and Clinical Sciences (BKV), Linköping University, Linköping, Sweden.
- Microbiology and Cell Science Department, University of Florida, Gainesville, Florida, USA.
- Division of Bioinformatics, Department of Physics, Chemistry and Biology, Linköping University, Linköping, Sweden.
- PredictMe AB, Linköping, Sweden.
- Crown Princess Victoria Children's Hospital, Linköping University Hospital, Linköping, Sweden.
ORCID-Profile: Maria Lerm, Johnny Ludvigsson
Förderung
- Medical Research Council of Southeast Sweden (FORSS); JDRF Wallenberg Foundation
Zitieren
APA
Alipoor, S. D., Ahrens, A., Åkesson, J., Hillerton, T., Gustafsson, M., Lerm, M., & Ludvigsson, J. (2026). Epigenetic analyses suggest different pathways during pregnancy for development of type 1 diabetes in children with high versus low‐neutral human leukocyte antigen‐risk. Journal of Internal Medicine, 299(5), 570-586. https://doi.org/10.1111/joim.70077
Vancouver
Alipoor SD, Ahrens A, Åkesson J, Hillerton T, Gustafsson M, Lerm M, et al. Epigenetic analyses suggest different pathways during pregnancy for development of type 1 diabetes in children with high versus low‐neutral human leukocyte antigen‐risk. Journal of Internal Medicine. 2026;299(5):570-586. doi:10.1111/joim.70077
BibTeX
@article{Alipoor2026,
author = {Alipoor, Shamila D and Ahrens, Angelica and Åkesson, Julia and Hillerton, Thomas and Gustafsson, Mika and Lerm, Maria and Ludvigsson, Johnny},
title = {Epigenetic analyses suggest different pathways during pregnancy for development of type 1 diabetes in children with high versus low‐neutral human leukocyte antigen‐risk},
journal = {Journal of Internal Medicine},
year = {2026},
volume = {299},
number = {5},
pages = {570--586},
doi = {10.1111/joim.70077}
}
EUVIMED